Gesynta, Pharma

/ C O R R E C T I O N -- Gesynta Pharma/

Veröffentlicht: 17.03.2026 um 17:49 Uhr, prnewswire.co.uk

Gesynta Pharma Sweden

View original content:https://www.prnewswire.co.uk/news-releases/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat-302711084.html

en | boerse | 68716910 |